Breast Cancer Blog

Stay up-to-date on breast cancer risk assessment, research, and treatment on the Cristine Meredith Miele Breast Cancer Blog. We'll post important new developments to keep you informed.

CMMF_Drug Pipeline

New Drug Testing for Multiple Cancers

Through new drug testing, scientists hope to use a certain protein to block the growth of multiple cancers, regardless of origin. The research centers around a protein called P53 that essentially tells a normal, healthy cell to die if its DNA is too badly damaged. Cancer cells block this protein, allowing for the replication of […]

Continue Reading
CMMF_Tamoxifen

New Study About Breast Cancer Drug Tamoxifen

A new study reported by the New York Times has found that breast cancer patients who take the drug Tamoxifen for 10 years rather than the standard five lessen their chances of recurrence of the disease and death. Tamoxifen is a drug that has been prescribed to cancer patients to block the effects of the […]

Continue Reading
CMMF_Tula

Tula the Boutique Fundraiser

Tula the Boutique at the Grove West will be donating a portion of all sales tomorrow, March 16th, to the Cristine Meredith Miele Foundation. They are also hosting a Nicole Miller trunk show to give you even more of a reason to stop by. Angela and Sarah have worked hard to make sure it will […]

Continue Reading
CMMF_Genetic Scientist

Genetic Role in Metastatic Breast Cancer

Genetic science has been hailed by many as the next frontier for drug development, improved health and increased longevity. While there are two sides to the genetic debate, there can be no question that some of the advances reflect excellent science and drive significant benefits. For example, the drug Herceptin very successfully treats breast cancer […]

Continue Reading
CMMF_Hospital

Sloan Researchers Discover a Key to Breast Cancer’s Ability to Spread

New research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered. The findings support the study of therapies that target this survival capacity and force the death of latent […]

Continue Reading